Literature DB >> 7393203

The distribution of bound propranolol between the different human serum proteins.

S Glasson, R Zini, P d'Athis, J P Tillement, J R Boissier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7393203

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN： 0026-895X            Impact factor:   4.436


× No keyword cloud information.
  21 in total

1.  Analysis of Drug Interactions with Lipoproteins by High-Performance Affinity Chromatography.

Authors:  Matthew R Sobansky; David S Hage
Journal:  Adv Med Biol       Date:  2012

2.  Binding of prazosin and propranolol at variable alpha 1-acid glycoprotein and albumin concentrations.

Authors:  G Sager; R Jaeger; C Little
Journal:  Br J Clin Pharmacol       Date:  1989-02       Impact factor: 4.335

3.  Biointeraction analysis of carbamazepine binding to alpha1-acid glycoprotein by high-performance affinity chromatography.

Authors:  Hai Xuan; K S Joseph; Chunling Wa; David S Hage
Journal:  J Sep Sci       Date:  2010-08       Impact factor: 3.645

4.  Microdialysis evaluation of the ocular pharmacokinetics of propranolol in the conscious rabbit.

Authors:  K D Rittenhouse; R L Peiffer; G M Pollack
Journal:  Pharm Res       Date:  1999-05       Impact factor: 4.200

Review 5.  Studies of metabolite-protein interactions: a review.

Authors:  Ryan Matsuda; Cong Bi; Jeanethe Anguizola; Matthew Sobansky; Elliott Rodriguez; John Vargas Badilla; Xiwei Zheng; Benjamin Hage; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2013-11-25       Impact factor: 3.205

6.  Binding of beta-adrenoceptor blocking drugs to human serum albumin, to alpha 1-acid glycoprotein and to human serum.

Authors:  F M Belpaire; M G Bogaert; M Rosseneu
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

7.  Total and free serum haloperidol levels in schizophrenic patients and the effect of age thioridazine and fatty acid on haloperidol-serum protein binding in vitro.

Authors:  F J Rowell; S M Hui; A F Fairbairn; D Eccleston
Journal:  Br J Clin Pharmacol       Date:  1981-04       Impact factor: 4.335

8.  Analysis of drug interactions with high-density lipoprotein by high-performance affinity chromatography.

Authors:  Sike Chen; Matthew R Sobansky; David S Hage
Journal:  Anal Biochem       Date:  2009-10-13       Impact factor: 3.365

9.  Decrease in penbutolol protein binding as a consequence of treatment with some alkylating agents.

Authors:  C Aguirre; J M Rodríguez-Sasiain; R Calvo
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

10.  Tianeptine binding to human plasma proteins and plasma from patients with hepatic cirrhosis or renal failure.

Authors:  R Zini; D Morin; C Salvadori; J P Tillement
Journal:  Br J Clin Pharmacol       Date:  1990-01       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.